. . . . . . . . . "\"Aranesp is contraindicated in patients with: Uncontrolled hypertension [see Warnings and Precautions ( 5.3 )] Pure red cell aplasia (PRCA) that begins after treatment with Aranesp or other erythropoietin protein drugs [see Warnings and Precautions ( 5.6 )] Serious allergic reactions to Aranesp [see Warnings and Precautions ( 5.7 )] Uncontrolled hypertension ( 4 Pure red cell aplasia (PRCA) that begins after treatment with Aranesp or other erythropoietin protein drugs ( 4 Serious allergic reactions to Aranesp ( 4\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "QSvUuZJa+RTcbSkP/zgsd3/RYRri+CXFLx4fnUtwo1so825xMCdnhT2cT+Vk8o4RGgH9QiyUiC7u2bQ309iXdikM/YCrg7T+9w/G+/i/pmbuQN7t3rDLLumFs1YB27QotZjb1uawtXazMDlm3glJQ0NowB/l+MALSDIOIKE2CDo=" . . "2021-08-23T17:56:07.507+02:00"^^ . . . . .